Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
99.72
-1.96 (-1.93%)
Mar 20, 2026, 11:04 AM EDT - Market open
Protagonist Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$106.67
Upside
+6.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $107 → $110 | Buy | Maintains | $107 → $110 | +10.31% | Mar 19, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $95 → $106 | Buy | Maintains | $95 → $106 | +6.30% | Mar 19, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $115 → $125 | Strong Buy | Maintains | $115 → $125 | +25.35% | Mar 19, 2026 |
| Barclays | Barclays | Buy Maintains $113 → $119 | Buy | Maintains | $113 → $119 | +19.33% | Mar 19, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $65 → $95 | Hold | Maintains | $65 → $95 | -4.73% | Mar 3, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $100 | Strong Buy | Maintains | $90 → $100 | +0.28% | Feb 26, 2026 |
| Barclays | Barclays | Buy Maintains $108 → $113 | Buy | Maintains | $108 → $113 | +13.32% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $102 → $112 | Buy | Maintains | $102 → $112 | +12.31% | Feb 26, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $95 → $118 | Strong Buy | Maintains | $95 → $118 | +18.33% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $117 | Strong Buy | Maintains | $80 → $117 | +17.33% | Jan 30, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $88 → $110 | Strong Buy | Maintains | $88 → $110 | +10.31% | Jan 5, 2026 |
| Barclays | Barclays | Buy Maintains $88 → $108 | Buy | Maintains | $88 → $108 | +8.30% | Dec 17, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $98 → $115 | Strong Buy | Maintains | $98 → $115 | +15.32% | Dec 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $96 → $98 | Strong Buy | Maintains | $96 → $98 | -1.72% | Nov 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $68 → $81 | Buy | Maintains | $68 → $81 | -18.77% | Nov 7, 2025 |
| Barclays | Barclays | Buy Maintains $72 → $88 | Buy | Maintains | $72 → $88 | -11.75% | Nov 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.